New research reveals that male circumcision could reduce HIV infection rates by up to 60 percent, which could prevent 5.7 million new cases and 3 million deaths over 20 years in sub-Saharan Africa. Dr. Robert Bailey, professor of epidemiology at the University of Illinois, Chicago, School of Public Health, discusses his research findings with host Dr. Larry Kaskel, highlighting HIV infection rates in areas of Africa where the male population is circumcised, and explaining the mechanism by which HIV infection may occur in uncircumcised men.
Circumcision Reduces the Risk of HIV Infection
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
New research reveals that male circumcision could reduce HIV infection rates by up to 60 percent, which could prevent 5.7 million new cases and 3 million deaths over 20 years in sub-Saharan Africa. Dr. Robert Bailey, professor of epidemiology at the University of Illinois, Chicago, School of Public Health, discusses his research findings with host Dr. Larry Kaskel, highlighting HIV infection rates in areas of Africa where the male population is circumcised, and explaining the mechanism by which HIV infection may occur in uncircumcised men.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli</span> </p>
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 credits
<p>Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 credits
<p>Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?